Form D · Other Technology
Allium Labs, Inc.
New York, NY · CIK 0001938040
Offering snapshot reported Jul 28, 2026 · SEC filing
- Reported sold
- $40M Offering amount: $40M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 26, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 28, 2026 | Initial | $39,999,994 | No comparison | 6 | SEC filing |
| Jul 15, 2022 | Initial | $4,249,998 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-592372
Source: Form D, filed Jul 28, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Beyer | Director |
| Yi Sheng Chan | Director, Executive, Promoter |
| Cheng Han Lee | Director, Executive, Promoter |
| Tomasz Tunguz | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
169 Madison Ave. #2169
New York, NY, 10016
New York, NY, 10016